Monitoring with non-wearable and wearable devices reduces hospitalizations by detecting early signs of deterioration and enhancing self-care behaviour. While the initial investment can be high, the long-term cost-effectiveness is supported by reduced hospitalisations. AI is increasingly integrated into monitoring systems, enhancing predictive accuracy and personalized care. Remote monitoring reduces mortality and hospitalisations in patients with HF, with benefits in cost-effectiveness, and the potential to optimize care delivery by integrating AI. Future research should focus on identifying monitoring strategies for specific HF populations, such as patients with advanced HF.
Pim van der Harst (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: